Philadelphia-based robotics firm Asylon has raised $26 million in a Series B funding round led by Insight Partners, with participation from Veteran Ventures Capital, Allegion Ventures, and the GoPA Fund.
Philadelphia-based robotics firm Asylon has raised $26 million in a Series B funding round led by Insight Partners, with participation from Veteran Ventures Capital, Allegion Ventures, and the GoPA Fund.
Paris-headquartered pharmaceutical company Sanofi has announced its intention to acquire British biotech firm Vicebio in a deal worth up to €1.36 billion.
GetASAP ASIA, a startup founded by two teenage entrepreneurs—16-year-old Raghav Arora and 19-year-old Pranavkrishna Suresh—has raised $3.45 million in pre-seed funding to transform the way small retailers in Southeast Asia access and manage their supply chains.
As defense tech attracts increasing investment amid rising global tensions, many startups focus on weapons systems and combat hardware. Rune Technologies, however, is zeroing in on a critical but often ignored domain: military logistics.
Blue Longevity Clinic, a healthtech startup focused on longevity medicine, has secured €2 million in funding to scale its operations across Southeast Europe.
London-based solar subscription startup Sunsave has secured £113 million (around €130.5 million) in a combination of £13M in Series A equity and a £100M debt facility from Crédit Agricole CIB.
London-based fintech Xelix has raised €137 million (approximately $160 million) in a Series B round led by Insight Partners, with continued backing from Passion Capital and LocalGlobe.
Andy Byron was born on September 14, 1974, in Hanover, Massachusetts, later moving to Duxbury. He attended Trinity–Pawling School and then earned a bachelor's degree in political science from Providence College in 1997, where he also played baseball as a pitcher.
Auxxo, the Berlin-based VC firm focused on supporting startups with at least one female founder, has announced a €26 million first close of its second fund — the Auxxo Female Catalyst Fund II.
